Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects (Q60563334)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects |
clinical trial |
Statements
A Phase 1, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of mRNA 1325 Zika Vaccine in Healthy Adults in a Non-endemic Zika Region (English)
0 references
31 December 2016
0 references
28 February 2019
0 references
90
0 references